CHICAGO TRUST Co NA Makes New Investment in Kenvue Inc. $KVUE

Key Points

• CHICAGO TRUST Co NA has purchased a new stake in Kenvue Inc., acquiring 21,591 shares valued at approximately $452,000 during the second quarter.
• Analysts have recently adjusted their price targets for Kenvue, with Bank of America lowering its target from $27.00 to $25.00, while other firms have varied ratings from "strong sell" to "overweight" based on current market conditions.
• Kenvue announced an increase in its quarterly dividend to $0.2075 per share, equating to an annual yield of 4.8%, reflecting a positive change from its previous dividend distribution.

CHICAGO TRUST Co NA bought a new stake in Kenvue Inc. (NYSE:KVUE - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 21,591 shares of the company's stock, valued at approximately $452,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in KVUE. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of Kenvue by 4.0% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 106,140 shares of the company's stock valued at $2,545,000 after buying an additional 4,034 shares in the last quarter. Arlington Partners LLC purchased a new position in Kenvue during the 2nd quarter valued at about $2,110,000. IFP Advisors Inc lifted its position in Kenvue by 25.3% during the 1st quarter. IFP Advisors Inc now owns 15,278 shares of the company's stock valued at $369,000 after acquiring an additional 3,081 shares during the period. Vident Advisory LLC bought a new stake in Kenvue during the first quarter worth about $520,000. Finally, AG2R LA Mondiale Gestion D Actifs purchased a new stake in Kenvue in the first quarter worth about $1,725,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Bank of America cut their price target on Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a research note on Tuesday, July 15th. Zacks Research upgraded shares of Kenvue to a "strong sell" rating in a research note on Monday, August 11th. Evercore ISI decreased their target price on shares of Kenvue from $23.00 to $18.00 and set an "in-line" rating for the company in a report on Tuesday. JPMorgan Chase & Co. decreased their price target on Kenvue from $27.00 to $26.00 and set an "overweight" rating for the company in a research note on Friday, July 25th. Finally, Royal Bank Of Canada lowered their price objective on shares of Kenvue from $24.00 to $22.00 and set a "sector perform" rating on the stock in a research report on Friday, August 8th. Four analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Kenvue currently has an average rating of "Hold" and a consensus price target of $23.32.

Kenvue Trading Up 1.7%

Shares of KVUE stock opened at $17.26 on Wednesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The company has a market cap of $33.11 billion, a price-to-earnings ratio of 23.32, a PEG ratio of 2.44 and a beta of 0.83. Kenvue Inc. has a 1 year low of $16.89 and a 1 year high of $25.17. The firm has a fifty day moving average price of $20.69 and a 200-day moving average price of $21.96.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.01. The business had revenue of $3.84 billion during the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.Kenvue's revenue for the quarter was down 4.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.8%. The ex-dividend date was Wednesday, August 13th. This is a positive change from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio (DPR) is 112.16%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.